Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features

Document Type

Article

Publication Title

FASEB Journal

First Page

3313

Last Page

3324

DOI

https://doi.org/10.1096/fj.14-251207

Publication Date

8-2014

Share

COinS